Email Alert | RSS    帮助

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (12): 1239-1242.doi: 10.3969/j.issn.1000-6621.2021.12.003

• 指南·规范·共识 • 上一篇    下一篇

结核病患者接种新型冠状病毒疫苗的专家建议

卢水华中华医学会结核病学分会   

  • 收稿日期:2021-09-27 出版日期:2021-12-10 发布日期:2021-12-01
  • 基金资助:
    国家自然科学基金(81770011)

Expert advice on anti-novel coronavirus vaccination for tuberculosis patients

Tuberculosis Branch of Chinese Medical Association   

  • Received:2021-09-27 Online:2021-12-10 Published:2021-12-01

摘要:

新型冠状病毒肺炎疫情仍在全球大范围流行,作为控制疫情的重要措施,新型冠状病毒疫苗接种正在全球范围内推广。结核病人群是新型冠状病毒感染和疾病重症化的高危人群,应优先考虑疫苗接种。但是,对于结核病患者是否能够接种以及如何接种新型冠状病毒疫苗,目前暂无足够多的高质量循证医学证据。为此,中华医学会结核病学分会基于世界卫生组织有关建议,以及我国相关技术指南,结合结核病患者实际情况,提出针对这一特殊人群疫苗接种的专家指导意见,建议除处于抗结核强化期治疗或合并其他病情不稳定慢性疾病的活动性结核病患者外,均应接种新型冠状病毒疫苗。

关键词: 结核, 新型冠状病毒, 疫苗, 接种

Abstract:

The epidemic of Corona Virus Disease 2019 (COVID-19) is still widespread in the world. As an important measure to control the epidemic, the COVID-19 vaccine is being promoted worldwide. Tuberculosis (TB) patients are high risk group to be infected by COVID-19 and suffer severe, therefore, priority vaccinate should be given to them. However, at present, there is not enough evidence of high quality evidence-based medicine for whether TB patients could be vaccinated and how to vaccinated COVID-19 vaccine. Based on WHO recommendations and related technical guidelines in China, as well as combined with the actual situation of TB patients, the Tuberculosis Branch of Chinese Medical Association, put forward the expert advice on vaccination for this special group. It is recommended that all TB patients should be vaccinated except for active TB patients in the course of anti-tuberculosis reinforcement or combined with other unstable chronic diseases.

Key words: Tuberculosis, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Vaccine, Vaccinate